Back to Search
MOHAMED SORROR, M.D., M.SC.
M.D., M.SC.
Medical Oncology Physician
NPI: 1972767978IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD60162884(WA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1993
Research & Publications (20)
Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes.
PMID 19147097·Biol Blood Marrow Transplant·2009
6-review
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 18794548·J Clin Oncol·2008
8-other
Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
PMID 18408584·Transplantation·2008
7-preclinical
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
PMID 18311781·Cancer·2008
8-other
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
PMID 17916744·Blood·2008
4-observational
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
PMID 17873123·Blood·2007
4-observational
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
PMID 17724349·J Clin Oncol·2007
8-other
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
PMID 15994282·Blood·2005
8-other
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
PMID 15809448·J Clin Oncol·2005
4-observational
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
PMID 15113759·Blood·2004
4-observational
Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences.
PMID 19450761·Biol Blood Marrow Transplant·2009
4-observational
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
PMID 19015394·Blood·2009
3-trial
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
PMID 18940675·Biol Blood Marrow Transplant·2008
3-trial
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
PMID 18759762·Br J Haematol·2008
4-observational
Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation.
PMID 18275897·Biol Blood Marrow Transplant·2008
8-other
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens.
PMID 18209720·Bone Marrow Transplant·2008
4-observational
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
PMID 18056679·J Clin Oncol·2008
4-observational
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
PMID 18022580·Biol Blood Marrow Transplant·2007
8-other
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
PMID 17697966·Biol Blood Marrow Transplant·2007
3-trial
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
PMID 17317589·Biol Blood Marrow Transplant·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 825 EASTLAKE AVE E
SEATTLE, WA 98109 - Phone
- (206) 288-1000
Quick Facts
- NPI
- 1972767978
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile